Stanford spinout's latest deal looks to unlock new fix for sickle cell disease
The initial Stanford research, studying how to make more bone marrow more receptive to gene therapies and stem cell transplants and less toxic for patients, was backed by nearly $23 million in grants from California's stem cell research funding agency.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Funding | Gene Therapy | Genetics | Grants | Health Management | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Toxicology | Transplants